Get started

Resistance_level

CNC: ON WATCH FOR A $25 MOVECNC: CNC is now retesting a multi-year resistance around $75. The resistance line has started in August 2018. The trend is up. Resistances are made to be broken and a stock that breaks through a multi-year resistance level can lead to a significant rally. It's often even better if the resistance level is at the stocks all-time high since there is no overhead resistance. I will be looking for a break and weekly close above 75 to enter a long swing position. This one is for patient investors/traders. If we break, I would target a 1st target of $100. Trade safe!
NYSE:CNCLong
by Elpidaldo
EURUSD-Weekly Market Analysis-Jan22,Wk2A Happy New Year to you. Yes, we are back on our Weekly Market Analysis, how have you been? EURUSD on the 4hourly chart we have a Bearish Gartley Pattern that will be good for a shorting opportunity as the candle respected the PRZ zone of the Gartley Pattern more than the 1 that form in the GBPUSD. Check the comments at the bottom of TradingView for quick access. However, breaking and closing above the red line or X for the conservative traders, and that will change our perspective and may not trade the Harmonic Pattern as the ascending triangle got back on track. I'm waiting for market open and will engage the trade 2hours after the market open. If the market gap up, I will forgo the trade.
Short
by RaynLim
What's up with Netflix $NFLXFor this analysis we are looking at the daily timeframe. NFLX is in a nice uptrend, but currently we are seeing a retracement, which is the chance to buy a nice stock at a smaller price. Netflix recently broke the upper resistance of an ascending triangle formation, which is a bullish sign. The break was followed by a fastly reached ATH from which the price dropped to the 550$ mark, which is 1. supported by a weekly trendline (TL) and 2. the upper resistance (now support) of the previously broken triangle pattern, which suggests that rn could be a good time to enter a long position, right? But before spending your hard earned money right away, have a look at the $NFLX earnings (January 27th). $NFLX lately tends to fail analyst expectations on earning reports (and $NFLX tends to perform better in Q1-Q3), the rather small drops after failing those kind of reports (as long as the expectations aren't missed drastically) tend to be corrected after a couple weeks, but this drop in price could give you a chance to buy a second position. Idea: enter a long position during the next week (since we need confirmation that our supports are stable), your TP could be at the previous ATH (21% gain if you decide to enter where I will enter (you can see the trade entry on my chart)) As always: no financial advice
NASDAQ:NFLXLong
by SimpForProfit
USDCAD Reversal?USDCAD just had it's highest daily close of 2021 on Friday 17th December, at 1.28912. Daily highs have exceeded this level 3 times this year but each time the price was rejected and the price failed to close above that level. So as priced has reached the highest daily close since December 22nd 2020, it has entered this area of rejection shown on the chart, while also displaying clear Bearish RSI Divergence as price climbs to the high while RSI slopes down. While we may be in a new uptrend - creating a new higher low in October and pushing for new 52week highs would suggest so - this looks close to a prime spot for USDCAD to take a breather and see a short term reversal. That being said, this is absolutely a spot where waiting for some confirmation of a reversal is a must - at the time of writing the momentum on lower time frames is strong, and bulls will have their eyes set on the nice round number of 1.29500, just a hairs breadth above the high of year achieved on August 20th.
Short
by HayeTrading
1
NQ Power Range Report with FIB Ext - 12/17/2021 SessionCME_MINI:NQH2022 - PR High: 15878.25 - PR Low: 15812.00 Evening Stats (As of 1:27 AM) - Gap: = N/A - Session Open ATR: 341.09 - Volume: 52k - Open Int: 210k - Trend Grade: Neutral - From ATH: -5.5% (Rounded) Key Levels (Rounded - Think of these as a range) - Long: 16963 - Mid: 16391 - Short: 15819 Keep in mind this is not speculation or a prediction. Only a report of the Power Range with Fib extensions for target hunting. Do your DD! You determine your risk tolerance. You are fully capable of making your own decisions.
CME_MINI:NQH2022Short
by mv3trader5
EURUSD DESCENDING CHANNELGot a descending channel here, My first target is the purple zone, 2nd target is the bottom of the channel. If you have any questions, leave a comment. Also if you have a different analysis of what is to come, let me know in the comments. If you like this idea, like and follow my account :) I do weekly analysis for overall direction for the week, every sunday, as well as post daily on daytrades or short term swings I am planning to take. DO NOT EXECUTE A TRADE JUST BECAUSE A STRANGER ON THE INTERNET HAS A COMPELLING ANALYSIS> DO YOUR OWN ANALYSIS.
Short
by Wickalodeon-GhostProductions
GBPAUD SELL The market has been trending upwards for quite a while now. Having broken the higher highs of that bull leg to find major resistance zone. from this point we will have to hop on the intraday time frames to look out for possible reversal patterns , secondly to look for possible structure . then finally lower lows and lower highs . that the chance to hop in . we need confirmations that the market will sell and create trends in the lower time frame , for us to get involved .
Short
by DIGITALASSETSINC
$LGVN entry PT 25 Target PTs 43-49 and higherLongeveron stock is up by a multiple of 11 after the FDA gave a Rare Pediatric Disease designation for a heart medication last week. Longeveron Inc., a clinical stage biotechnology company, engages in developing cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications comprising aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida.
NASDAQ:LGVNLong
by BADQOMOCAWGOWLD
1